Genetic and phenotypic analysis of dilated cardiomyopathy with conduction system disease: Demand for strategies in the management of presymptomatic lamin A/C mutant carriers

[1]  P. Flemming,et al.  LMNA Mutations in Cardiac Transplant Recipients , 2005, Cardiology.

[2]  L. Melton,et al.  Epidemiology of Idiopathic Dilated and Hypertrophic Cardiomyopathy , 2005 .

[3]  S. Benedetti,et al.  Laminopathies: from the heart of the cell to the clinics , 2004, Current opinion in neurology.

[4]  D. Fatkin,et al.  Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. , 2004, The Journal of clinical investigation.

[5]  Richard T. Lee,et al.  Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. , 2004, The Journal of clinical investigation.

[6]  H. Worman,et al.  How do mutations in lamins A and C cause disease? , 2004, The Journal of clinical investigation.

[7]  H. Crijns,et al.  Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? , 2004, Journal of Molecular Medicine.

[8]  L. Tavazzi,et al.  Loss of lamin A/C expression revealed by immuno-electron microscopy in dilated cardiomyopathy with atrioventricular block caused by LMNA gene defects , 2003, Virchows Archiv.

[9]  M. Komajda,et al.  Functional consequences of an LMNA mutation associated with a new cardiac and non‐cardiac phenotype , 2003, Human mutation.

[10]  L. Mestroni,et al.  Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. , 2003, Journal of the American College of Cardiology.

[11]  R. Hershberger,et al.  A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation. , 2002, American heart journal.

[12]  C. Hutchison.  Lamins: building blocks or regulators of gene expression? , 2002, Nature Reviews Molecular Cell Biology.

[13]  Eloisa Arbustini,et al.  Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. , 2002, Journal of the American College of Cardiology.

[14]  R. Hershberger,et al.  Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease. , 2001, Journal of cardiac failure.

[15]  J. Seidman,et al.  The Genetic Basis for Cardiomyopathy from Mutation Identification to Mechanistic Paradigms , 2001, Cell.

[16]  C. Hutchison,et al.  Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes? , 2001, Journal of cell science.

[17]  B. Eymard,et al.  High Incidence of Sudden Death with Conduction System and Myocardial Disease Due to Lamins A and C Gene Mutation , 2000, Pacing and clinical electrophysiology : PACE.

[18]  M. Manns,et al.  Three novel mutations, c314C>A, C778insC, and c1285+2T>A, in exon 2 of the Wilson disease gene , 2000, Human mutation.

[19]  L. Mestroni,et al.  Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. , 2000, Circulation.

[20]  R. Hetzer,et al.  A new frameshift mutation at codon 466 (1397delA) within the LMNA gene , 2000, Human mutation.

[21]  J. Seidman,et al.  Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. , 1999, The New England journal of medicine.

[22]  L. Mestroni,et al.  Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. , 1999, European heart journal.

[23]  H. Katus,et al.  Frequency and phenotypes of familial dilated cardiomyopathy. , 1998, Journal of the American College of Cardiology.

[24]  D. Levy,et al.  Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation. , 1997, Circulation.

[25]  A. di Lenarda,et al.  Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The Heart Muscle Disease Study Group. , 1997, European heart journal.

[26]  W. McKenna,et al.  Familial dilated cardiomyopathy in the United Kingdom. , 1995, British heart journal.

[27]  S. Coughlin,et al.  Idiopathic dilated cardiomyopathy. , 1994, The New England journal of medicine.

[28]  L. Mestroni,et al.  Molecular genetics of dilated cardiomyopathy. , 1994, Herz.

[29]  A. Tajik,et al.  The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. , 1992, The New England journal of medicine.

[30]  P. Poole‐Wilson.  Idiopathic dilated cardiomyopathy. , 1990, BMJ.

[31]  L. Melton,et al.  Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. , 1989, Circulation.

[32]  J. Ware,et al.  Echocardiographic Measurements in Normal Subjects from Infancy to Old Age , 1980, Circulation.

[33]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[34]  H Sandler,et al.  The use of single plane angiocardiograms for the calculation of left ventricular volume in man. , 1968, American heart journal.

[35]  A. Whitfield.  Familial cardiomyopathy. , 1961, The Quarterly journal of medicine.